No Data
Earnings Preview: ABCL to Report Financial Results Post-market on November 04
$AbCellera Biologics(ABCL.US)$ is scheduled to release its financial results post-market on November 04 ET. Earnings PreviewAnalysts estimate $AbCellera Biologics(ABCL.US)$ to post revenue of USD8.01
CORRECTION: Abacus Life Ticker Is 'ABL'
Abacus Life Sees Prelim. Q3 Total Revenue $26M-$28M Vs $29.256M Est.
We Think AbCellera Biologics (NASDAQ:ABCL) Needs To Drive Business Growth Carefully
AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
Press Release: AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024